EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a Biosafety Level 1 Cellular Assay for Identifying Small-Molecule Antivirals Targeting the Main Protease of SARS-CoV-2: Evaluation of Cellular Activity of GC376, Boceprevir, Carmofur, Ebselen, and Selenoneine

Yasunori Fukumoto iD, Noriyuki Suzuki, Reina Hara, Yu-Ki Tanaka iD, Yasumitsu Ogra iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25115767 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yasunori Fukumoto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan. Hauptthemen laut MEDLINE: Antiviral Agents, SARS-CoV-2, Organoselenium Compounds, Isoindoles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Japan Ministry of Education, Culture, Sports, Science, and Technology, Kikkoman Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While research has identified several inhibitors of the main protease (Mpro) of SARS-CoV-2, a significant portion of these compounds exhibit reduced activity in the presence of reducing agents, raising concerns about their effectiveness in vivo. Furthermore, the conventional biosafety level 3 (BSL-3) for cellular assays using viral particles poses a limitation for the widespread evaluation of Mpro inhibitor efficacy in a cell-based assay. Here, we established a BSL-1 compatible cellular assay to evaluate the in vivo potential of Mpro inhibitors. This assay utilizes mammalian cells expressing a tagged Mpro construct containing N-terminal glutathione S-transferase (GST) and C-terminal hemagglutinin (HA) tags and monitors Mpro autodigestion. Using this method, GC376 and boceprevir effectively inhibited Mpro autodigestion, suggesting their potential in vivo activity. Conversely, carmofur and ebselen did not exhibit significant inhibitory effects in this assay. We further investigated the inhibitory potential of selenoneine on Mpro using this approach. Computational analyses of binding energies suggest that noncovalent interactions play a critical role in facilitating the covalent modification of the C145 residue, leading to Mpro inhibition. Our method is straightforward, cost-effective, and readily applicable in standard laboratories, making it accessible to researchers with varying levels of expertise in infectious diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsSARS-CoV-2Organoselenium CompoundsIsoindolesCoronavirus 3C ProteasesAzolesProlineHumansMolecular Docking SimulationProtease InhibitorsCOVID-19 Drug TreatmentCOVID-19HEK293 CellsLactamsLeucineSulfonic Acids

Stichwörter der Autor:innen

GC376MproSARS-CoV-2binding energy calculationboceprevircarmofurebselenselenoneine

Substanzen

Antiviral AgentsebselenOrganoselenium CompoundsIsoindolesCoronavirus 3C ProteasesAzolesProlineN-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobut…GC376Protease Inhibitors

Autor:innen und Institutionen

  • Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.

ORCID-Profile: Yasunori Fukumoto, Yu-Ki Tanaka, Yasumitsu Ogra

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Ministry of Education, Culture, Sports, Science, and Technology
  • Kikkoman Corporation

Zitieren

APA

Fukumoto, Y., Suzuki, N., Hara, R., Tanaka, Y. K., & Ogra, Y. (2024). Development of a Biosafety Level 1 Cellular Assay for Identifying Small-Molecule Antivirals Targeting the Main Protease of SARS-CoV-2: Evaluation of Cellular Activity of GC376, Boceprevir, Carmofur, Ebselen, and Selenoneine. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25115767

Vancouver

Fukumoto Y, Suzuki N, Hara R, Tanaka YK, Ogra Y. Development of a Biosafety Level 1 Cellular Assay for Identifying Small-Molecule Antivirals Targeting the Main Protease of SARS-CoV-2: Evaluation of Cellular Activity of GC376, Boceprevir, Carmofur, Ebselen, and Selenoneine. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25115767

BibTeX
@article{Fukumoto2024,
  author = {Fukumoto, Yasunori and Suzuki, Noriyuki and Hara, Reina and Tanaka, Yu-Ki and Ogra, Yasumitsu},
  title = {Development of a Biosafety Level 1 Cellular Assay for Identifying Small-Molecule Antivirals Targeting the Main Protease of SARS-CoV-2: Evaluation of Cellular Activity of GC376, Boceprevir, Carmofur, Ebselen, and Selenoneine},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25115767}
}
Kostenlos starten →